These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1280532)

  • 41. Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension.
    Broderick TL; King TM
    Med Sci Monit; 2008 Dec; 14(12):BR261-4. PubMed ID: 19043358
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension.
    Partovian C; Adnot S; Eddahibi S; Teiger E; Levame M; Dreyfus P; Raffestin B; Frelin C
    Am J Physiol; 1998 Dec; 275(6):H1948-56. PubMed ID: 9843792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension.
    Fontoura D; Oliveira-Pinto J; Tavares-Silva M; Leite S; Vasques-Nóvoa F; Mendes-Ferreira P; Lourenço AP; Leite-Moreira AF
    Rev Port Cardiol; 2014 Apr; 33(4):213-22. PubMed ID: 24780128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension.
    Umar S; Hessel M; Steendijk P; Bax W; Schutte C; Schalij M; van der Wall E; Atsma D; van der Laarse A
    Pathol Res Pract; 2007; 203(12):863-72. PubMed ID: 17913382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endogenous endothelin-1 mediates cardiac hypertrophy and switching of myosin heavy chain gene expression in rat ventricular myocardium.
    Ichikawa KI; Hidai C; Okuda C; Kimata SI; Matsuoka R; Hosoda S; Quertermous T; Kawana M
    J Am Coll Cardiol; 1996 Apr; 27(5):1286-91. PubMed ID: 8609357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Farnesoid-X-receptor expression in monocrotaline-induced pulmonary arterial hypertension and right heart failure.
    Ye L; Jiang Y; Zuo X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):164-70. PubMed ID: 26392308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension.
    Kato T; Nasu T; Sonoda H; Ito KM; Ikeda M; Ito K
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):18-23. PubMed ID: 18209564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM; Keane PM; Suyama KL; Gauthier D
    Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat.
    Kögler H; Hartmann O; Leineweber K; Nguyen van P; Schott P; Brodde OE; Hasenfuss G
    Circ Res; 2003 Aug; 93(3):230-7. PubMed ID: 12842921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism.
    Pei Y; Ma P; Wang X; Zhang W; Zhang X; Zheng P; Yan L; Xu Q; Dai G
    Eur J Pharmacol; 2011 Sep; 666(1-3):165-72. PubMed ID: 21641341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen and enalapril attenuate the development of right ventricular hypertrophy induced by monocrotaline in ovariectomized rats.
    Ahn BH; Park HK; Cho HG; Lee HA; Lee YM; Yang EK; Lee WJ
    J Korean Med Sci; 2003 Oct; 18(5):641-8. PubMed ID: 14555814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective effects of drag-reducing polymers in a rat model of monocrotaline-induced pulmonary hypertension.
    Wang Y; Hu F; Mu X; Wu F; Yang D; Zheng G; Sun X; Gong K; Zhang Z
    Biorheology; 2016 Jan; 53(1):13-22. PubMed ID: 26889655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of myoglobin in hypertrophied rat cardiomyocytes in experimental pulmonary hypertension.
    Peters EL; Offringa C; Kos D; Van der Laarse WJ; Jaspers RT
    Pflugers Arch; 2016 Oct; 468(10):1697-707. PubMed ID: 27572699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of exercise on monocrotaline-induced changes in right heart function and pulmonary artery remodeling in rats.
    Colombo R; Siqueira R; Becker CU; Fernandes TG; Pires KM; Valença SS; Souza-Rabbo MP; Araujo AS; Belló-Klein A
    Can J Physiol Pharmacol; 2013 Jan; 91(1):38-44. PubMed ID: 23368696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trapidil improves hemodynamic, echocardiographic and redox state parameters of right ventricle in monocrotaline-induced pulmonary arterial hypertension model.
    Türck P; Lacerda DS; Carraro CC; de Lima-Seolin BG; Teixeira RB; Poletto Bonetto JH; Colombo R; Schenkel PC; Belló-Klein A; da Rosa Araujo AS
    Biomed Pharmacother; 2018 Jul; 103():182-190. PubMed ID: 29653363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study.
    Todorovich-Hunter L; Johnson DJ; Ranger P; Keeley FW; Rabinovitch M
    Lab Invest; 1988 Feb; 58(2):184-95. PubMed ID: 3123799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.